SCHEMBL6802898

SCHEMBL6802898

COC(=O)C(=O)C=CC(=O)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.39
MAPT P10636 3/20 0.39
TET2 Q6N021 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
GAA P10253 2/20 0.34
TSHR P16473 2/20 0.33
POLB P06746 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CYP2C9 P11712 1/20 0.31
DNMT1 P26358 1/20 0.31
CYP2C19 P33261 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16277267 0.89 NFE2L2 (0.68) HCAR2KEAP1NFE2L2ALDH1A1KDM4E
SCHEMBL5222112 0.89 NFE2L2 (0.68) HCAR2KEAP1NFE2L2ALDH1A1KDM4E
SCHEMBL28977419 0.89 HCAR2 (0.56) HCAR2KEAP1NFE2L2ALDH1A1KDM4E
SCHEMBL12609248 0.85
SCHEMBL12651643 0.85
SCHEMBL7031398 0.85
SCHEMBL14240081 0.84 HCAR2 (0.36) HCAR2KEAP1NFE2L2ALDH1A1KDM4E
SCHEMBL7070305 0.83 HCAR2 (0.39) HCAR2KEAP1NFE2L2ALDH1A1KDM4E
SCHEMBL7070307 0.83 HCAR2 (0.39) HCAR2KEAP1NFE2L2ALDH1A1KDM4E
SCHEMBL15835920 0.83 HCAR2 (0.35) HCAR2KEAP1NFE2L2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040014652-A1 Tumor activated prodrug compounds and methods of making and using the same DIATOS SA (FR) 2004-01-22 US disclosed
EP-1286700-A2 TUMOR ACTIVATED PRODRUG COMPOUNDS UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2003-03-05 EP disclosed
WO-2001091798-A2 TUMOR ACTIVATED PRODRUG COMPOUNDS UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2001-12-06 WO disclosed